CareDx (CDNA) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
CareDx Reports Fourth Quarter and Full Year 2019 Results
February 27, 2020 4:05 PM ESTSOUTH SAN FRANCISCO, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high value healthcare solutions for transplant patients and caregivers, today reported financial results for the fourth quarter and full year ended December 31, 2019.
Recent Highlights:
Achieved total revenue of $35.8 million for the three months ended December 31, 2019, increasing 52% year-over-yearProvided over 14,000 patient results in the fourth quarter and approximately 49,000 patient results in 2019As of December 31, 2019, over 30 U.S.-based transplant centers... More